Aurobindo Pharma Limited (AUROPHARMA) — FY26 Annual Report | 29 July 2026
Aurobindo Pharma announced its 39th Annual General Meeting scheduled for August 27, 2026, via video conference, with the integrated annual report for FY25-26 to be distributed to shareholders and posted on its website.
About Aurobindo Pharma Limited (AUROPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when AUROPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AUROPHARMA — Free💡 Ask AI about this filing
📊 More AUROPHARMA filings
- Announcement — 24 July 2026 Aurobindo Pharma announced a non-exclusive voluntary license agreement with MSD to manufacture and s...
- 🔴 Announcement — 23 July 2026 Aurobindo Pharma announced that its subsidiary Apitoria Pharma will acquire 80% ownership of A1 Bioc...
- Announcement — 21 July 2026 Aurobindo Pharma announced that its wholly owned subsidiary CuraTeQ Biologics received ANVISA approv...
- Announcement — 2 July 2026 Aurobindo Pharma announced the completion of transferring its domestic branded generic pharmaceutica...
- Announcement — 2 July 2026 Aurobindo Pharma announced it has completed dematerialization of securities for the quarter ended Ju...
🔥 Also filed on 29 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AUROPHARMA files new disclosures
Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AUROPHARMA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research